$QURE 0.26 Weak

Notable posts

• @StockSavvyShay bullish 150 eng

  $CLPT is up 34% after the FDA allowed $QURE to use three-year Phase I/II AMT-130 data as primary basis for an accelerated approval BLA filing planned for Q3 2026. ClearPoint is moving because AMT-130 is delivered directly into the brain using its navigation system and SmartFlow cannula meaning every trial procedure and potentially every commercial procedure if approved runs through its platform.

  view on X →
• @wallstengine neutral 125 eng

  uniQure $QURE says FDA feedback supports using 3-year Phase I/II AMT-130 data as the primary basis for a BLA seeking accelerated approval in Huntington’s disease. BLA planned for Q3 2026. ClearPoint $CLPT is also moving as AMT-130 is delivered using its navigation system and SmartFlow cannula.

  view on X →
• @TENETTRADEGROUP neutral 31 eng

  Tenet Pre-Market Movers June.17.26 $QURE $CLPT $NEOV $LZB $MNTS $MCRP $AEHR $ACMR $PDYN $ASTS $ASML $KMX $INTC $ABCL $MU $AMD $VSTM $OUST $SOFI $MYSE $YQ $IMDX $LION $SOPH $JBL @ripster47 | @tenet_research | @TenetCharts https://t.co/wY29QBvqXP

  view on X →
• @tenet_research neutral 25 eng

  Tenet Market Wake-Up Summary 📷📷 June.18.26 $SPX $AAPL $INTC $AVGO $OKLO $LEU $META $TSLA $NOK $RUM $UUUU $QBTS $ONDS $ZETA $PFE $SPCX $TSEM $MRVL $SWBI $ACN $KR $ALB $ENPH $QURE $CEG $TLN $CURB $ENGN $INTU $CAST $LNKS $LPA $NVCR $LEGN @ripster47 | @tenet_research | @TenetCharts

  view on X →
• @tenet_research neutral 20 eng

  Tenet Market Wake-Up Summary 📷📷 June.17.26 $SPX $AMZN $ASTS $INTC $OUST $SMR $HOOD $COIN $NFLX $AEHR $ORCL $MSFT $MNTS $IONQ $KTOS $LZB $JBL $KMX $CRL $MAC $HUN $ALGT $IQV $RMD $ZGN $LDOS $QURE $CLPT $MYSE $YQ $IMDX @ripster47 | @TENETTRADEGROUP | @TenetCharts https://t.co/UZqrXoliGx

  view on X →